We've found
3,276
archived clinical trials in
Pancreatic Cancer
We've found
3,276
archived clinical trials in
Pancreatic Cancer
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Updated: 3/19/2018
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials
Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer
Updated: 3/19/2018
Phase I/IIA: Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer
Status: Enrolling
Updated: 3/19/2018
Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer
Updated: 3/19/2018
Phase I/IIA: Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Updated: 4/5/2018
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Updated: 4/5/2018
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Updated: 4/5/2018
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Updated: 4/5/2018
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Updated: 4/5/2018
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Updated: 4/5/2018
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Updated: 4/5/2018
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Updated: 4/5/2018
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Updated: 4/5/2018
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Updated: 4/5/2018
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Molecularly Tailored Therapy for Pancreas Cancer
Updated: 4/6/2018
A Pilot Study of Molecularly Tailored Therapy for Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 4/6/2018
Molecularly Tailored Therapy for Pancreas Cancer
Updated: 4/6/2018
A Pilot Study of Molecularly Tailored Therapy for Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 4/6/2018
Click here to add this to my saved trials
Molecularly Tailored Therapy for Pancreas Cancer
Updated: 4/6/2018
A Pilot Study of Molecularly Tailored Therapy for Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 4/6/2018
Molecularly Tailored Therapy for Pancreas Cancer
Updated: 4/6/2018
A Pilot Study of Molecularly Tailored Therapy for Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 4/6/2018
Click here to add this to my saved trials
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
Updated: 4/11/2018
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemotherapy With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/11/2018
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
Updated: 4/11/2018
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemotherapy With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/11/2018
Click here to add this to my saved trials
Study of SBP-101 in Pancreatic Cancer
Updated: 4/18/2018
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
Study of SBP-101 in Pancreatic Cancer
Updated: 4/18/2018
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
Click here to add this to my saved trials
Study of SBP-101 in Pancreatic Cancer
Updated: 4/18/2018
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
Study of SBP-101 in Pancreatic Cancer
Updated: 4/18/2018
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
Click here to add this to my saved trials
Study of SBP-101 in Pancreatic Cancer
Updated: 4/18/2018
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
Study of SBP-101 in Pancreatic Cancer
Updated: 4/18/2018
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
Click here to add this to my saved trials
Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic Cancer
Updated: 4/24/2018
A Phase 1 Study of Hypofractionated Stereotactic Radiotherapy and Concurrent HIV Protease Inhibitor Nelfinavir as Part of a Neoadjuvant Regimen in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic Cancer
Updated: 4/24/2018
A Phase 1 Study of Hypofractionated Stereotactic Radiotherapy and Concurrent HIV Protease Inhibitor Nelfinavir as Part of a Neoadjuvant Regimen in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Updated: 4/24/2018
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Updated: 4/24/2018
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Updated: 4/24/2018
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Updated: 4/24/2018
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Updated: 4/24/2018
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Updated: 4/24/2018
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Updated: 4/24/2018
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Updated: 4/24/2018
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Updated: 4/24/2018
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Updated: 4/24/2018
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Click here to add this to my saved trials